2nd Quarter - Termination
CAPITOL COUNSEL LLC for AMICUS THERAPEUTICS, INC.
Firm
Client
Income
$20,000
Expenses
—
Terminated
Apr 15, 2026
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
| KAREN STONE | — |
Medicare/Medicaid MMM
Legislative and regulatory issues affecting SMID rare disease biotech companies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
| KAREN STONE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.